The 17th China International Polypeptide Conference was successfully concluded in Tianjin on June 14-16, 2023!

CPS2023 hosted by Nankai University with the theme of "Peptides: Innovative Applications to Build the Future", CPS2023 will focus on the following three specific areas of discussion: 1) peptides and chemistry; 2) Polypeptides and organisms; 3) Peptides and drugs. The conference will showcase the new achievements and developments in peptides and related fields at home and abroad in recent years, enhance the exchange and cooperation of scholars at home and abroad, promote the deep integration of industry, university and research, and promote the research and industrial development of peptides in China and even the world.

Exhibition site

Motif Biotech was invited to participate in the exhibition, and the on-site academic exchange atmosphere was rich, during which the exhibitors of Murduff Bio had a warm discussion with the guests present and colleagues in the industry, and introduced the latest research progress of the company in the leading fields of polypeptide and nucleic acid CRDMO service.

Suzhou Motif Biotech Co., Ltd. was founded in 2021, with peptide technology as the core, along with the completion of the R&D base of the headquarters, is committed to developing into an international peptide CRO and CDMO enterprise integrating peptide scientific research and customization, peptide drug research and development, peptide drug process development, and peptide API production.

To the end:

At present, the CDMO project of Suzhou Motif Biotech Co., Ltd. has completed the research and development of GLP-1 category, and the research and development projects of antibacterial polypeptides, immune polypeptides, anti-wrinkle polypeptides, anti-tumor polypeptides and other pipelines are also in progress. The company focuses on providing peptide API process technology development services, peptide drug clinical research API customization services and peptide cGMP API large-scale production services.